Adverse effects of amikacin on preterm infants kidneys
Not Applicable
- Conditions
- Bacterial sepsis of newborn.Bacterial sepsis of newborn
- Registration Number
- IRCT2015103124804N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Appropriate for gestational age preterm infants with early onset sepsis diagnosis
Exclusion criteria:neonates with incomplete treatment ; whom their parents do not accept to be included in this trial ; asphyxia; kidney anomalies in ultrasonography
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rinary NGAL rising. Timepoint: at admission before initialling amikacin and at 7th day after completing treatment. Method of measurement: Using Urinary NGAL kit.
- Secondary Outcome Measures
Name Time Method Serum cr & BUN rising. Timepoint: at admission and 3th, 5th and 7th day. Method of measurement: by blood sampling.